Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden
Authors:
- Maryline Mb BonnetMBMaryline Mb Bonnet
- Loretxu Lp PinogesLPLoretxu Lp Pinoges
- Francis Fv VaraineFVFrancis Fv Varaine
- Barbara Bo OberhauserBOBarbara Bo Oberhauser
- Daniel Do O'BrienDODaniel Do O'Brien
- Yared Yk KebedeYKYared Yk Kebede
- Cathy Ch HewisonCHCathy Ch Hewison
- Rony Rz ZachariahRony Rz Zachariah
- Laurent Lf FerradiniLFLaurent Lf Ferradini
- 12 June 2006
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (9) , 1275-1279
Abstract
HAART reduces tuberculosis (TB) incidence in people living with HIV/AIDS but those starting HAART may develop active TB or subclinical TB may become apparent in the immune reconstitution inflammatory syndrome. To measure the incidence rate of notified TB in people receiving HAART in five HIV programmes occurring in low-resource countries with a high TB/HIV burden. A retrospective review in five Médecins Sans Frontières programmes (Cambodia, Thailand, Kenya, Malawi and Cameroon) allowed incidence rates of notified TB to be calculated based on follow-up time after HAART initiation. Among 3151 patients analysed, 90% had a CD4 cell count of < 200 cells/mul. Median follow-up time ranged from 3.7 months in Thailand or Kenya to 11.1 months in Cambodia. Incidence rates were 7.6, 10.4, 17.6, 14.3 and 4.8/100 person-years for pulmonary TB and 12.7, 4.3, 6.9, 2.1 and 0/100 person-years for extra-pulmonary TB in the programmes in Cambodia, Thailand, Kenya, Malawi and Cameroon, respectively. Overall, 62.3% of pulmonary TB and 54.9% of extra-pulmonary TB were diagnosed within 3 months after HAART initiation. High incidence rates of notified TB under HAART in programmes held in poor-resource countries were observed; these were likely to include both undiagnosed prevalent TB at HAART initiation and subclinical TB developing during the immune reconstitution inflammatory syndrome. This raises operational issues concerning TB diagnosis and treatment of TB/HIV-coinfected patients and prompts for urgent TB and HIV care integration.Keywords
This publication has 16 references indexed in Scilit:
- Risk Factors for Active Tuberculosis after Antiretroviral Treatment Initiation in AbidjanAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Immune restoration disease after antiretroviral therapyAIDS, 2004
- Clinical implications of stopping nevirapine‐based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistanceHIV Medicine, 2004
- Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosisAIDS, 2003
- The Growing Burden of TuberculosisArchives of internal medicine (1960), 2003
- Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort studyThe Lancet, 2002
- Reduced Risk of Tuberculosis among Brazilian Patients with Advanced Human Immunodeficiency Virus Infection Treated with Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2002
- Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infectionAIDS, 2000
- Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected Patients after the Introduction of Highly Active Antiretroviral TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in UgandaAIDS, 2000